2.
Variables | All
(N=1,335) |
Ib1
(n=743) |
Ib2
(n=348) |
IIa1
(n=175) |
IIa2
(n=69) |
SCC
(n=1,199) |
AC/ASC
(n=126) |
DFS, disease-free survival; OS, overall survival; AT, adjuvant therapy; SCC, squamous cell carcinoma; AC/ASC, adenocarcinoma/adenosquamous carcinoma. | |||||||
Cases received
AT [n (%)] |
822 (61.6) | 417 (56.1) | 232 (66.7) | 128 (73.1) | 45 (65.2) | 728 (60.7) | 87 (69.0) |
2-year DFS (%) | 95.6 | 96.6 | 92.9 | 95.8 | 91.6 | – | – |
5-year DFS (%) | 92.1 | 93.1 | 86.7 | 92.5 | 88.7 | 92.9 | 89.5 |
5-year OS (%) | 95.0 | 97.6 | 88.4 | 93.2 | 87.9 | 96.2 | 92.4 |